01—History
EPS (Diluted) History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $10.46
02—Ledger
EPS (Diluted), period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $10.46 | +18.3% | 10-K | |
| FY2024 | $8.84 | +85.3% | 10-K | |
| FY2023 | $4.77 | −65.9% | 10-K | |
| FY2022 | $13.97 | −42.7% | 10-K | |
| FY2021 | $24.39 | +53.6% | 10-K | |
| FY2020 | $15.88 | +90.2% | 10-K | |
| FY2019 | $8.35 | −3.0% | 10-K | |
| FY2018 | $8.61 | −27.1% | 10-K | |
| FY2017 | $11.81 | +73.2% | 10-K | |
| FY2016 | $6.82 | +56.8% | 10-K | |
| FY2015 | $4.35 | −26.4% | 10-K | |
| FY2014 | $5.91 | −5.4% | 10-K | |
| FY2013 | $6.25 | +4.3% | 10-K | |
| FY2012 | $5.99 | +17.2% | 10-K | |
| FY2011 | $5.11 | −3.4% | 10-K | |
| FY2010 | $5.29 | +6.2% | 10-K | |
| FY2009 | $4.98 | +19.7% | 10-K | |
| FY2008 | $4.16 | +5.9% | 10-K | |
| FY2007 | $3.93 | — | 10-K |
03—Questions
What is eps (diluted)?
Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.
What is Labcorp Holdings's current eps (diluted)?
Labcorp Holdings (LH) annual eps (diluted) for 2025 was $10.46, a 18.33% increase from 2024. Labcorp Holdings eps (diluted) for the quarter ending September 30, 2026 was $3.22.
What was Labcorp Holdings's eps (diluted) in 2024?
Labcorp Holdings annual eps (diluted) for 2024 was $8.84, a 85.32% increase from 2023.
What was Labcorp Holdings's eps (diluted) in 2023?
Labcorp Holdings annual eps (diluted) for 2023 was $4.77, a 65.86% decline from 2022.
What is Labcorp Holdings's 5-year eps (diluted) CAGR?
Labcorp Holdings eps (diluted) grew at a compound annual growth rate (CAGR) of 8.01% from FY2020 to FY2025, going from $15.88 to $10.46 over 5 years.
- Company
- Labcorp Holdings
- Ticker
- LH
- Sector
- Healthcare
- Industry
- Services-Medical Laboratories